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Macrophage and dendritic cell (DC) progenitors
(MDPs) and common DC progenitors (CDPs) are
bone marrow (BM) progenitors with DC differentia-
tion potential. However, both MDPs and CDPs give
rise to large numbers of conventional DCs (cDCs)
and few plasmacytoid DCs (pDCs), implying that
more dedicated pDC progenitors remain to be iden-
tified. Here we have described DC progenitors with
a prominent pDC differentiation potential. Although
both MDPs and CDPs express the macrophage col-
ony stimulating factor (M-CSF) receptor (M-CSFR),
the progenitors were confined to a M-CSFR frac-
tion, identified as Linc-Kitint/loFlt3+M-CSFR, and
expressed high amounts of E2-2 (also known as
Tcf4) an essential transcription factor for pDC devel-
opment. Importantly, they appeared to be directly
derived from either CDPs or lymphoid-primed multi-
potent progenitors (LMPPs). Collectively, our find-
ings provide insight into DC differentiation pathways
and may lead to progenitor-based therapeutic appli-
cations for infection and autoimmune disease.
INTRODUCTION
Dendritic cells (DCs) have crucial functions in the initiation of
innate and adaptive immunity in infection and inflammation
and in the induction of tolerance under steady-state conditions
(Banchereau and Steinman, 1998). DCs consist of conventional
DCs (cDCs) and plasmacytoid DCs (pDCs) (Banchereau and
Steinman, 1998; Liu, 2005; Shortman and Naik, 2007; Geiss-
mann et al., 2010; Swiecki andColonna, 2010). pDCs are present
in human (Siegal et al., 1999; Cella et al., 1999) and mouse
(Asselin-Paturel et al., 2001; Nakano et al., 2001; Bjo¨rck, 2001)
and are characterized by their capacity to produce large
amounts of type I interferons (IFNs) (Siegal et al., 1999; Cella
et al., 1999; Asselin-Paturel et al., 2001; Nakano et al., 2001;
Bjo¨rck, 2001). The pDCs’ activation and type I IFN productionare critical for the initiation of antiviral immune responses,
whereas pDCs’ activation in the absence of infection causes
autoimmune diseases, such as systemic lupus erythematosis
(SLE) and psoriasis vulgaris (Gilliet et al., 2008; Banchereau
and Pascual, 2006). In addition, local microenvironments can
induce tolerogenic properties in pDCs (de Heer et al., 2004;
Goubier et al., 2008). It was recently shown that basic helix-
loop-helix transcription factor E2-2 (also known as TCF4) is
essential for pDC development in both human andmouse (Naga-
sawa et al., 2008; Cisse et al., 2008) and maintenance of mature
pDCs (Ghosh, et al., 2010).
DCs are originated from hematopoietic stem cells (HSCs) in
the bone marrow (BM) via intermediate progenitors (Shortman
and Naik, 2007; Geissmann et al., 2010; Merad and Manz,
2009). The intermediate sequential progenitors are classified on
the basis of their chemokine and cytokine receptor expression
and in vivo DC differentiation ability (Fogg et al., 2006; Auffray
et al., 2009; Liu et al., 2009; Onai et al., 2007; Naik et al., 2007).
Fms-like tyrosine kinase receptor-3 (Flt3) has a nonredundant
role in the steady-state differentiation and maintenance of
pDCs and cDCs in vivo. Mice deficient for Flt3 or Flt3-ligand
(Flt3L) are poor producers of cDCs and pDCs in vivo (McKenna
et al., 2000; Waskow et al., 2008), and the recently identified
macrophage and DC progenitors (MDPs) and common DC pro-
genitors (CDPs) express Flt3 on their cell surface (Cisse et al.,
2008; Fogg et al., 2006; Auffray et al., 2009; Liu et al., 2009).
MDPs express the phenotypic markers LinCX3CR1
+CD11b
c-Kit+Flt3+M-CSFR+ and produce macrophages and cDCs and
pDCs through CDPs (Fogg et al., 2006; Onai et al., 2007; Naik
et al., 2007; Auffray et al., 2009; Liu et al., 2009), whereas CDPs
are Linc-Kitint/loFlt3+M-CSFR+ cells that give rise exclusively to
cDCs and pDCs (Onai et al., 2007; Naik et al., 2007), suggesting
that CDPs are stringently committed to the DC lineage. The
immediate cDC precursors, namely pre-DCs, which are derived
from CDPs, migrate into lymphoid and some nonlymphoid
tissues where they differentiate into cDCs (Naik et al., 2006,
2007; Varol et al., 2009; Bogunovic et al., 2009; Ginhoux et al.,
2009). Notably, both MDPs and CDPs give rise to many fewer
pDCs than cDCs. In this study, we identified DC-committed
progenitors, i.e., Linc-Kitint/loFlt3+M-CSFRIL-7Ra cells, with
prominent pDC differentiation potential, and our findings revise
the current understanding of DC differentiation pathways.Immunity 38, 943–957, May 23, 2013 ª2013 Elsevier Inc. 943
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Identification of M-CSFR– DC Progenitors
Because the MDPs and CDPs express M-CSFR, we initially
examined whether DC developmental potential was exclusive
to the M-CSFR+ fraction of Lin BM cells (Figure S1 available
online). Lin BM cells were divided into four populations in terms
of their c-Kit and M-CSFR expression: c-KithiM-CSFR (R1),
c-Kit+M-CSFR+ (R2), c-Kitint/loM-CSFR+ (R3), and c-Kitint/loM-
CSFR (R4) cells (Figure S1A). R1 contained HSCs, multipotent
progenitors (MPPs), and myeloid progenitors (MPs), and R2–R4
included MDPs (R2), CDPs (R3), and B cell progenitors (R4),
respectively. In the presence of M-CSF, about 50% of R2
and a few percent of R1 and R3 gave rise to macrophage col-
onies, but R4 did not give rise to any macrophage colonies
(Figure S1B).
To examine the DC differentiation potential of each fraction,
we cultured the cells ex vivo in the presence of Flt3L for
8 days. Not only the LinM-CSFR+ fractions (R2 and R3), which
include the MDPs and CDPs (Fogg et al., 2006; Onai et al., 2007;
Naik et al., 2007), but also the LinM-CSFR fractions (R1 and
R4) showed DC differentiation potential (Figures S1C and
S1D). Among the latter fractions, we expected the c-KithiM-
CSFR cells (R1) to give rise to DCs, because this population
contains the HSCs, MPPs, and MPs. The development of DCs
from c-Kitint/loM-CSFR (R4) cells was unexpected, but these
cells had a relatively stronger pDC differentiation potential (Fig-
ures S1C and S1D). Because only LinFlt3+ cells have DC differ-
entiation potential (D’Amico and Wu, 2003; Karsunky et al.,
2003), we focused on Linc-Kitint/loFlt3+M-CSFR cells as
a likely population for the pDC precursors; we also exclu-
ded the interleukin-7 receptor a chain-positive (IL-7Ra+) cells
from the Linc-Kitint/loFlt3+M-CSFR fraction (hereafter, Linc-
Kitint/loFlt3+M-CSFR cells), because this population contains
B cell progenitors (Figure 1A; Onai et al., 2007). The proportion
of Linc-Kitint/loFlt3+M-CSFR cells was 0.1% in the whole BM
cells and the ratio of Linc-Kitint/loFlt3+M-CSFR cells (R1) and
CDPs (R2) was 1:1 (Figure 1A).
To evaluate the DC developmental potential of the Linc-
Kitint/loFlt3+M-CSFR cells in comparison with CDPs ex vivo,
we cultured 2 3 104 Linc-Kitint/loFlt3+M-CSFR cells and
CDPs in Flt3L-supplemented medium for 4, 8, and 12 daysFigure 1. Identification of M-CSFR– DC Progenitors
(A) Flow cytometric sorting of BM Lin cells (left), those expressing Linc-Kitint/loF
areas: R1, Linc-Kitint/loFlt3+M-CSFRIL-7Ra; R2, CDPs (Linc-Kitint/loFlt3+M-C
(B–E) Ex vivo DC differentiation from sorted Linc-Kitint/loFlt3+M-CSFRIL-7Ra
(B) Cells (2 3 104) were cultured in the presence of human Flt3L-Ig (100 ng/ml) a
CD24lo cDCs) subpopulations on day 4, 8, and 12 of culture.
(C) Flow cytometric profiles of the DC subsets.
(D) PDCA-1 or Siglec-H expression (shaded) and corresponding isotype controls
(E) IFN-a production (1 mM CpG for 24 hr) on day 8 of culture.
(F) On day 8 of culture, pDCs derived from Linc-Kitint/loFlt3+M-CSFRIL-7Ra cel
supernatants was evaluated by ELISA.
ND, not detected. Means ± SEM are shown. n = 8 from five (A–D) or three (E, F)
(G) Division-coupled differentiation into pDCs from Linc-Kitint/loFlt3+M-CSFRIL
cultured in the presence of hFlt3L-Ig (100 ng/ml) for 2 days and 7 days.
(H) May-Gru¨nwald-Giemsa staining of sorted pDCs derived from Linc-Kitint/loFlt
Data are representative of three independent experiments.
See also Figure S1.(Figure 1B). On day 8, when the number of pDCs reached its
peak, the Linc-Kitint/loFlt3+M-CSFR cells gave rise exclu-
sively to DCs, and the majority of their progeny were pDCs
(CD45RA+CD11cint); the rest were cDCs (CD45RACD11c+)
containing both the CD11bloCD24hi and CD11bhiCD24lo sub-
populations (Figures 1B, left and 1C, left). As reported previ-
ously (Onai et al., 2007; Naik et al., 2007), CDPs gave rise to
a large number of cDCs and a few pDCs (Figures 1B, right
and 1C, right). On day 8, the absolute number of pDCs gener-
ated from Linc-Kitint/loFlt3+M-CSFR cells was 6–8 times
higher than that from CDPs. However, CDPs produced 3- to
4.5-fold more cDC subsets (Figure 1B). The CD45RA+CD11cint
cells derived from Linc-Kitint/loFlt3+M-CSFR cells and CDPs
expressed plasmacytoid dendritic cell antigen-1 (PDCA-1)
and sialic acid binding Ig-like lectin (Siglec)-H, confirming that
they were genuine pDCs (Figure 1D). As expected from the
abundant pDCs, the progenies of Linc-Kitint/loFlt3+M-CSFR
cells produced higher amounts of IFN-a than did those of
CDPs after CpG stimulation (Figure 1E). Indeed, the same
numbers of pDCs derived from Linc-Kitint/loFlt3+M-CSFR
cells and CDPs produced IFN-a at comparable amounts
upon CpG stimulation (Figures 1F). The Linc-Kitint/loFlt3+
M-CSFR cells and CDPs showed similar proliferative poten-
tial ex vivo (Figure 1G), and the pDCs derived from the
Linc-Kitint/loFlt3+M-CSFR cells had a typical pDC morphol-
ogy (Figures 1H). From these results, we concluded that
Linc-Kitint/loFlt3+M-CSFR cells are DC-committed progeni-
tors with prominent pDC differentiation potential (hereafter,
M-CSFR DC progenitors).
Under the same culture conditions, 1 of 8.6 M-CSFRDC pro-
genitors (Figure 2A) and 1 of 7.1 CDPs (Figure 2B) gave rise to
CD11c+ cells as estimated by limiting-dilution analysis. That is,
43 out of 183 single-sorted M-CSFR DC progenitors gave rise
to CD11c+ cells, which included 22 clones generating only
pDCs, 12 generating only cDCs, and 9 generating both pDCs
and cDCs (Figure 2C). In the case of cDC-only colonies, some
contained both CD11bhiCD24lo and CD11bloCD24hi subpopula-
tions, and some contained only one of them (Figure 2D). In the
case of colonies that give rise to both cDCs and pDCs, the ratio
of pDCs to cDCs varied (Figure 2E). The results of limiting-dilu-
tion analysis of M-CSFR DC progenitors (Figure 2F and CDPs
(Figure 2G) were summarized as Venn diagrams, showing thatlt3+ (middle), and, of them, those expressing M-CSFR and IL-7Ra (right). Boxed
SFR+).
cells and CDPs.
nd absolute numbers of pDC (CD45RA+CD11cint) and cDC (CD24hi cDCs and
(open) on pDCs.
ls and CDPswere stimulatedwith CpG for 24 hr, and IFN-a activity in the culture
independent experiments.
-7Ra cells (left) and CDPs (right). DC progenitors were labeled with CFSE and
3+M-CSFRIL-7Ra cells (left) and CDPs (right). Original magnification, 3400.
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Figure 2. Limiting Dilution Analysis of M-CSFR–
DC Progenitors
(A and B) Limiting dilution analysis of M-CSFR DC
progenitors (A) and CDPs (B). Cells were cultured for
12 days with Ac6 stromal cells and hFlt3L-Ig
(100 ng/ml); each well was analyzed for CD11c+ cells.
Horizontal axis, number of plated cells. Dotted line, 37%
negative ‘‘readout’’ showing the predicted frequency of
CD11c+ progenitor cells in parentheses. Statistics
details are described in Experimental Procedures.
(C) Clonal analysis of M-CSFR DC progenitors. Single
progenitors gave rise to pDCs (left), cDCs (middle), or
both (right).
(D) Subsets of cDCs defined as in Figure 1C.
(E) Single bipotential progenitors gave rise to both pDCs
and cDCs. Some clones gave rise to comparable
numbers of pDCs and cDCs (left), some clones gave
rise to a large number of pDCs and some cDCs (middle),
and other clones gave rise to some pDCs and many
cDCs (right). Data are representative of three indepen-
dent experiments.
(F and G) Venn diagrams of the progenies of single
M-CSFR DC progenitors (F) or CDPs (G) sorted and
plated at a density of 1 cell per well in 96-well plates (for
a total of 182 wells) on irradiated Ac6 stromal cells in
human Flt3L-Ig-supplemented media. Values represent
the number of wells on day 12 with cells of the indicated
type. Data are combined from three independent
experiments.
See also Figure S2.
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to pDCs.
To further ensure DC-committed differentiation potential of
M-CSFR DC progenitors, we examined the myelo-erythroid
and B cell differentiation potential of M-CSFR DC progenitors
by using ex vivo assays for colony-forming units (CFU) (Figures
S2A–S2C). For comparison, Linc-KithiSca-1+ cells, which are
a mixture of HSCs and MPPs, were included. As reported previ-
ously (Fogg et al., 2006; Auffray et al., 2009; Liu et al., 2009; Onai
et al., 2007; Naik et al., 2007), MDPs contained colony-forming
activities for myeloid lineages, resulting in colonies of granulo-
cytes and macrophages or macrophages alone, but less than
3% of the CDPs produced myeloid colonies. In contrast,
M-CSFR DC progenitors contained few macrophage CFU
and completely lacked CFU for other myeloid lineages (Fig-
ure S2A). Furthermore, compared with MDPs, CDPs and
M-CSFR DC progenitors produced few macrophage colonies,
and neither of them produced pre-B cells (Figures S2B and S2C).
Therefore, we concluded that M-CSFR DC progenitors have
minimal myeloid differentiation potential and lack erythroid and
pre-B cell differentiation potential.
M-CSFR– DC Progenitors Highly Express E2-2
We further characterized in detail the molecular phenotypes of
the M-CSFR DC progenitors. First we examined their expres-
sion of cell surface molecules and found that they were positive
for CX3CR1, expressed PDCA-1 at minimal amounts, and were
negative for M-CSFR, MHC class II, CD11c, CD40, CD45RA,
Ly49Q, CCR9, and Siglec-H (Figure 3A). In this context, CDPs
expressed M-CSFR but never expressed PDCA-1 (Figure 3B).
In addition, DNAmicroarray analysis revealed that the M-CSFR
DC progenitors did not distinctly express other surface markers
including receptors for cytokines and chemokines (Table S1).
Several transcription factors critically regulate DC development
(Merad and Manz, 2009; Watowich and Liu, 2010; Belz and
Nutt, 2012): the basic helix-loop-helix transcription factor E2-2
specifically controls pDC development (Nagasawa et al., 2008;
Cisse et al., 2008; Ghosh et al., 2010), interferon regulatory factor
8 (IRF) controls the development of pDCs and certain cDC sub-
sets (Schiavoni et al., 2002, 2004; Aliberti et al., 2003; Tsujimura
et al., 2003), Batf3 is required for CD8a+ and CD103+ cDC devel-
opment (Hildner et al., 2008; Edelson et al., 2010), and PU.1,
encoded by Sfpi1, seems to regulate both cDC and pDC devel-
opment (Anderson et al., 2000; Guerriero et al., 2000; Onai et al.,
2006). Other factors controlling DC development include STAT3,
Gfi-1, Id2, and SpiB. We examined the expression profiles of
these DC development-associated genes in the M-CSFR DC
progenitors and in HSCs, MDPs, CDPs, pDCs, and cDCs (Fig-
ure 3C). Importantly, the M-CSFR DC progenitors expressed
the highest amounts of E2-2 among those tested, consistent
with their prominent pDC differentiation potential. They also
expressed critical DC lineage-associated genes, such as Irf8,
Sfpi1, Stat3, Gfi1, and SpiB at amounts comparable to CDPs,Figure 3. Characterization of M-CSFR– DC Progenitors
(A and B) Histograms showing surface markers of M-CSFR DC progenitors (A) a
isotype controls.
(C) RNAs for DC lineage-associated genes were analyzed by qPCR in HSCs, MD
Data are representative of three independent experiments. See also Table S1.
948 Immunity 38, 943–957, May 23, 2013 ª2013 Elsevier Inc.and Id2 at lower amounts than the other DC progenitors,
confirming their DC developmental potential. In contrast, Batf3
expression in the M-CSFR DC progenitors was negligible.
These results indicated that the molecular phenotypes of the
M-CSFR DC progenitors are suitable for DC progenitors and
the highest amounts of E2-2 expression is consistent with their
prominent pDC differentiation potential.
In Vivo Prominent pDC Differentiation Potential
of M-CSFR– DC Progenitors
To evaluate the in vivo differentiation potential of the M-CSFR
DC progenitors, 5 3 104 M-CSFR DC progenitors or CDPs
from B6 mice (CD45.1CD45.2+) were injected into irradiated
B6.SJL mice (CD45.1+CD45.2) (Figure 4). In line with our
ex vivo findings, the M-CSFR DC progenitors gave rise exclu-
sively to DCs and not to lineages including T, B, and NK cells,
or erythrocytes in the spleen and BM of the progenitor-injected
mice (Figures 4A and 4B). Furthermore, 10 days after the trans-
plantation, when the number of progeny cells peaked (Figure 4C),
most of the M-CSFR DC progenitors’ progenies were pDCs
(CD45RA+CD11cint) in these organs, which expressed additional
pDC markers, including PDCA-1 and Siglec-H (Figures 4A and
4B). Compared with CDPs, the M-CSFR DC progenitors gave
rise to 5–6 times more pDCs, but only 1/3 the number of cDCs
(Figure 4D). In addition, the M-CSFR DC progenitor-derived
pDCs and cDCs expressed normal amounts of Toll-like receptor
7 (TLR7) and TLR9 and of TLR2 and TLR4, respectively (Figures
4E and S3A); the pDCs were capable of producing robust IFN-a
in response to CpG stimulation ex vivo (Figure 4F); and the cDCs
effectively induced T cell proliferation in allogeneic mixed
lymphocyte reactions (MLRs) (Figure S3B). To further demon-
strate the biological relevance of the M-CSFR DC progenitors
in vivo, the M-CSFR DC progenitors, MDPs, and CDPs were
transplanted into irradiated mice. Ten days after transplantation,
CpG DNA+DOTAP was intravenously injected, and the serum
concentration of IFN-awas examined. Consistent with the prom-
inent pDC developmental potential of the M-CSFR DC progen-
itors, the mice that received these cells produced a significantly
higher amount of IFN-a than those transplanted with MDPs or
CDPs (Figure 4G). Because the LNs became too small to analyze
after irradiation, we also transplanted the M-CSFR DC progen-
itors into nonirradiated recipients and noted that they gave rise to
a large number of pDCs in the spleen, LNs, and BM (Figures
S3C–S3G). Of note, the progenies were mostly pDCs in the
BM, which is consistent with a previous report showing that
pDCs are abundantly present in the BM under steady-state
conditions (Zhang et al., 2006). In addition, the M-CSFR DC
progenitor-derived pDCs contained a larger number of CCR9
subpopulation in the BM than those in the spleen (Figures
S3E). To further examine whether DC progenitors give rise to
pDCs through CCR9 intermediate precursors (Schlitzer et al.,
2011), we cultured 2 3 104 M-CSFR DC progenitors in Flt3L-
supplemented medium for 2 or 4 days (Figure S3H). Thend CDPs (B). Shaded areas, indicated molecules; open areas, corresponding
Ps, CDPs, M-CSFR DC progenitors, pDCs, and cDCs.
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day 2 (data not shown) and started to express CCR9 on day 2. Its
amount had increased on day 4, showing that CCR9 intermedi-
ate precursors give rise to pDCs (Figure S3H). These results
collectively indicated that M-CSFR DC progenitors have excel-
lent pDC differentiation potential in vivo.
Rag1+ pDCs Are Derived from the M-CSFR– DC
Progenitors
Although pDCs are heterogeneous and 30%–40% of them
express Rag1 (Pelayo et al., 2005), CDPs are entirely Rag1
negative, implying the presence of other DC progenitors that
generate Rag1-positive pDCs (Reizis, 2010). To examine
whether the M-CSFR DC progenitors give rise to both Rag1-
positive and Rag1-negative pDCs in vivo, 5 3 104 M-CSFR
DC progenitors or CDPs of Rag1gfp/+ mice (CD45.1CD45.2+),
which express enhanced green fluorescent protein (EGFP)
under the endogenous Rag1 promoter (Kuwata et al., 1999),
were transplanted into irradiated B6.SJL mice (CD45.1+
CD45.2) (Figure 5). Of note, the majority of the CDPs
(99.9%) and the M-CSFR DC progenitors (97.9%) did not
express Rag1 (Figure 5A). Consistent with these results, the
DH-JH rearrangement was not detectable in the M-CSFR

DC progenitors or CDPs, although it was detected in these pro-
genitor-derived pDCs (Figure S4). Ten days after the transplan-
tation, M-CSFR DC progenitors had given rise to a 2:1 ratio of
Rag1-negative to Rag1-positive pDCs, whereas no Rag1-posi-
tive cDCs were detected in vivo (Figures 5B and 5F). Both pDC
subsets expressed CCR9, although a small fraction of the
Rag1-negative pDCs did not (Figure 5C). In contrast, most of
the CDP-derived pDCs were Rag1 negative (Figures 5D and
5F) and, regardless of the Rag1 expression, the majority of
pDCs expressed CCR9 (Figure 5E). These results suggested
that both Rag1-negative and -positive pDCs are mostly derived
from the M-CSFR DC progenitors in vivo. No Rag1-positive
cDCs were derived from either the CDPs or the M-CSFR DC
progenitors (Figure 5G).
Relationship between the M-CSFR– DC Progenitors
and CDPs
Finally, the relationship between the M-CSFR DC progenitors
and CDPs was examined. Based on the findings that the
M-CSFR DC progenitors do not express M-CSFR, whereas
MDPs and CDPs do express it (Figure 3A), that Flt3L and
M-CSF promote pDC development from CDPs (Onai et al.,
2007), and that Flt3L and thrombopoietin (TPO) promote pDCFigure 4. In Vivo Differentiation Potential of M-CSFR– DC Progenitors
(A and B) Flow cytometric profile of the spleen (A) and BM (B) 10 days after i.v. tra
(CD45.2+) into irradiated B6.SJL mice (CD45.1+). Progenies were stained for CD
(C and D) Absolute cell numbers of DC subsets in splenic progenies from M-CS
progenitors or CDPs at day 10 (D).
(E) Splenic pDC and cDC progenies were sorted, and the expression levels of Tlr7
experiments.
(F) Ten days after transplantation, M-CSFR DC progenitor (pro.)-derived pDCs
IFN-a concentrations in the culture supernatants were determined by ELISA.
(G) Sorted M-CSFR DC progenitor, CDPs, and MDPs were transplanted into le
plantation, CpG + DOTAP was intravenously injected, and 24 hr later the serum IF
independent experiments. ND, not detected.
Error bars in (C), (D), (F), and (G) show the mean ± SEM. *p < 0.01. See also Figu
950 Immunity 38, 943–957, May 23, 2013 ª2013 Elsevier Inc.development from human CD34+ cells (Chen et al., 2004), we
cultured M-CSFR DC progenitors, side by side with CDPs
and MDPs, in the presence of Flt3L alone or Flt3L and M-CSF
and/or TPO for 8 days. Compared with Flt3L alone, Flt3L
together with TPO further enhanced pDC differentiation from
the M-CSFR DC progenitors, and Flt3L together with M-CSF
and/or TPO significantly enhanced the differentiation of pDCs,
but not cDCs, from CDPs, and, to a lesser extent, from MDPs
(Figures 6A, 6B, S5A, and S5B). Of note, Flt3L induced the
expression of Mpl, a receptor for TPO, on the DC progenitors
(Figure 6C), allowing them to respond to TPO. Importantly, under
this culture condition, the progenitors’ E2-2 mRNA expression
was upregulated (Figures 6D, left, and S5C), whereas their
M-CSFR expression was downregulated although the amount
of M-CSFR downregulation by Flt3L and TPO was partial (Fig-
ures 6E and S5D), resulting in the M-CSFR DC progenitor-like
phenotype. Of note, when both M-CSF and TPO were added
together with Flt3L, their enhancing effects on pDC differentia-
tion were not additive. Consistent with these results, 3 days after
an intra-BM transfer of DC progenitors, the M-CSFR DC pro-
genitors had maintained their surface phenotype, whereas the
c-Kit and M-CSFR expression on CDPs and on nearly half of
the MDPs was downregulated (Figure S5E). These results sug-
gested that the M-CSFR DC progenitors might be derived
from CDPs that were stimulated with cytokines that upregulate
E2-2 expression, i.e., M-CSF and TPO.
In addition, an upstream Flt3+ progenitor might generate both
CDPs and the M-CSFR DC progenitors. To test this possibility,
we focused on lymphoid-primed MPPs (LMPPs, also known as
MPP4), which are Linc-Kit+Sca-1+CD34+Flt3+ and lack mega-
karyocyte and erythroid potential (Adolfsson et al., 2005; Wilson
et al., 2008), for the following reasons. First, megakaryocyte and
erythroid progenitors (MEPs) do not have DC developmental
potential (Onai et al., 2006). Second, granulocyte and monocyte
progenitors (GMPs) showed a very low pDC developmental
potential (data not shown). We transplanted CFSE-labeled
LMPPs (CD45.1CD45.2+) directly into the BM of nonirradiated
B6.SJL mice (CD45.1+CD45.2). Soon after the LMPPs divided
once, we identified daughter cells showing the surface pheno-
type of the M-CSFR DC progenitors (Figure 7A) that retained
their unique DC differentiation potential (Figures 7B and 7C).
Interestingly, this was also the case for MDPs and CDPs (Figures
7A–7C). In this context, our data include the previously proposed
differentiation pathways, i.e., the differentiation of GMPs and
MDPs into CDPs (Liu et al., 2009). On the basis of these findings,
we propose a new model for DC development, in whichnsplantation of 53 104 double-sorted M-CSFR DC progenitors from B6 mice
11c, CD45RA, PDCA-1, Siglec-H, CD3ε, CD19, NK1.1, and TER119.
FR DC progenitors at the indicated time points (C) and from M-CSFR DC
and Tlr9 were analyzed by qPCR. Data are representative of two independent
were sorted from the spleen and stimulated with 1 mM CpG for 24 hr, and the
thally irradiated B6.SJL mice with rescue bone marrow. Ten days after trans-
N-a concentration was determined by ELISA. Data are representative of three
re S3.
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Immunity
DC Progenitors Expressing High Amounts of E2-2M-CSFR DC progenitors are derived from either CDPs or
LMPPs (Figure S6).
DISCUSSION
Our findings extend the previous knowledge that DC-committed
progenitors are confined to the LinFlt3+ fraction (D’Amico and
Wu, 2003; Karsunky et al., 2003) to show that DC-committed
progenitors belong to the Linc-Kitint/loFlt3+IL-7Ra fraction
and that M-CSFR expression does not determine their presence.
Thus, we propose that DC-committed progenitors consist of the
M-CSFR DC progenitors and CDPs, with the former probably
arising downstream of the latter or LMPPs.
One could argue against the proposed relationship between
the M-CSFR DC progenitors and CDPs. When CDPs were
transferred in vivo, they gave rise to large numbers of cDCs
and few pDCs, seemingly arguing against the ex vivo findings
that CDPs stimulated with M-CSF and/or TPO become the
M-CSFR DC progenitor-like cells with prominent pDC differen-
tiation potential. In this context, progenitor transfer experiments
might be appropriate to demonstrate each progenitor’s own DC
differentiation potential. However, it is uncertain whether pro-
genitors transferred in vivo migrate to and settle in the ‘‘progen-
itor niche’’ where they are exposed to the appropriate cytokines
and other ligands necessary for the conversion fromCDPs to the
M-CSFR DC progenitors. Therefore, such transfer experiments
have some technical limitations and might not demonstrate the
physiological fate of the progenitor cells. In addition, our results
showed that LMPPs are a possible upstream progenitor for both
CDPs and the M-CSFR DC progenitors.
Besides these two DC-committed progenitors, other DC-
committed progenitor candidates are unlikely to be present in
the LinFlt3+ fraction, because the Linc-Kithi/+Flt3+ population
contains short-term HSCs, multipotent progenitors, earlier
progenitors upstream of MDPs, and MDPs, and the rest of the
Linc-Kitint/loFlt3+ cells are Linc-Kitint/loFlt3+M-CSFRIL-7Ra+,
with B cell differentiation potential. Based on previous findings
and our results, we propose the following scenario for DC devel-
opment. DC lineage commitment occurs in the Linc-
Kitint/loFlt3+IL-7Ra fraction upon receiving the Flt3 signal, which
plays a nonredundant role in DC development (McKenna et al.,
2000; Onai et al., 2006; Waskow et al., 2008). Then, the cells
receiving a second signal via M-CSFR or Mpl, a receptor for
TPO, upregulate E2-2 and reciprocally downregulate M-CSFR,
further committing them to the pDC lineage.
In this context, although M-CSF can induce pDCs and cDCs
ex vivo and in vivo independently of Flt3L, the numbers of
pDCs and cDCs generated are much reduced compared with
the effect of M-CSF in Flt3L-sufficient conditions (Fancke et al.,
2008), suggesting that the Flt3 signal is prerequisite for M-CSFFigure 5. M-CSFR– DC Progenitors as a Source of pDC Subsets
(A) Flow cytometric analysis of CDPs, M-CSFR DC progenitor, and classical lym
(B–G) Flow cytometric profile (B–E, G) and absolute numbers (F) of spleen progen
(B, C) and CDPs (D, E) from Rag1gfp/+ mice (CD45.2+) into irradiated B6.SJL mice
(C, E) amounts. The resulting cDCs were also analyzed for GFP amounts (G). Shad
open histograms represent results from corresponding isotype controls. Cell num
iments. Error bars in (F) show the mean ± SEM. *p < 0.01.
See also Figure S4.
952 Immunity 38, 943–957, May 23, 2013 ª2013 Elsevier Inc.to optimally influence DC development. In addition, M-CSF and
TPO (and probably even other cytokines) function redundantly
to upregulate E2-2. Therefore, mice lacking a single cytokine or
its receptor genemay be unlikely to show impaired pDCdevelop-
ment. In contrast to the M-CSF-induced downregulation of
M-CSFR, themechanism of TPO-inducedM-CSFR downregula-
tion remains unknown. The promoter region of M-CSFR contains
an E-box, which is an E2-2-binding site (Ovchinnikov et al.,
2010), implying that TPO-induced E2-2 might downregulate
M-CSFR. In addition, DNA microarray analysis revealed that,
except for M-CSFR, the expression amounts of receptors for
known cytokines and ligands were comparable between the
M-CSFR DC progenitors and CDPs The microenvironments in
the BM, i.e., the cells that physiologically secrete M-CSF and
TPO, by which CDPs acquire E2-2 and the distinct set of tran-
scriptional gene expressions associated with the pDC develop-
mental potential, remains an important issue to be addressed.
pDCs are heterogenous and can be divided into subpopula-
tions based on the expression of Rag1 and CCR9 (Pelayo
et al., 2005; Schlitzer et al., 2011). Because CDPs are uniformly
negative for Rag1, the possibility of a partial lymphoid contribu-
tion to pDC development or the presence of some other source
of pDCs that expresses Rag1 has been suggested (Reizis, 2010).
The M-CSFR DC progenitors described here gave rise to both
Rag1-negative and -positive pDCs in vivo. In addition, consistent
with a recent report identifying PDCA-1+CCR9 cells as a pDC
precursor (Schlitzer et al., 2011), the M-CSFR DC progenitors
gave rise to PDCA-1+CCR9+ pDCs via the PDCA-1+CCR9 pre-
cursor stage. Interestingly, the PDCA-1+CCR9 cells largely give
rise to pDCs in the BM and liver, but they give rise to both pDCs
and cDCs in other peripheral lymphoid organs, implying that their
DC developmental potential is affected by tissue-derived cyto-
kines that regulate the amounts of E2-2 and Id2 expression
(Schlitzer et al., 2012).
The M-CSFR DC progenitors gave rise to predominantly
pDCs and some cDCs, indicating that the identity of the progen-
itors hasn’t been definitively confirmed. In this context, because
they express only low amounts of PDCA-1, it is technically
impossible to clearly sort PDCA-1 and PDCA-1lo cells. Further-
more, cell surface staining for more than 20 different markers
including M-CSFR, MHC class II, CD11c, CD40, CX3CR1,
CD45RA, Ly49Q, CCR9, and Siglec-H and DNAmicroarray anal-
ysis revealed that the M-CSFR DC progenitors do not distinctly
express other surface markers, suggesting that the ability to
identify progenitors with a unique pDC differentiation potential
on the basis of surface markers is limited. Instead, because
they express the highest levels of E2-2 but still give rise to
some cDCs, it is likely that the M-CSFR DC progenitors repre-
sent a mixture of cells, the majority of which express E2-2 and
the rest of which express little or no E2-2 and probably containphoid progenitors (Linc-Kitint/loFlt3+M-CSFRIL-7Ra+) for Rag1 expression.
y 10 days after i.v. transplantation of 53 104 sorted M-CSFR DC progenitors
(CD45.1+). The resulting pDCs were further analyzed for GFP (B, D) and CCR9
ed histograms show CCR9 expression on Rag1 (left) and Rag1+ (right) pDCs;
bers are graphed in (F). Data are representative of three independent exper-
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DC Progenitors Expressing High Amounts of E2-2at least in part previous CDPs with retained cDC differentiation
potential; the former give rise strictly to pDCs, whereas the latter
give rise to cDCs. To identify progenitors with a unique pDC dif-
ferentiation potential will require an E2-2 reporter mouse. Based
on our findings, we suggest redefining CDPs to include both
E2-2lo and E2-2hi cells regardless of M-CSFR expression.
Given that pDCs contribute critically to the induction of anti-
viral immune responses (Banchereau and Steinman, 1998; Liu,
2005; Shortman and Naik, 2007; Geissmann et al., 2010; Swiecki
and Colonna, 2010), oral tolerance (Goubier et al., 2008), and the
development of autoimmune diseases (Gilliet et al., 2008;
Banchereau and Pascual, 2006), our discovery of genuine pDC
progenitors, which provides insight into DC differentiation
pathways, may also lead to progenitor-based therapies for viral
infection and autoimmune disease.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6 mice, Clea), B6.Cx3cr1
gfp/+ (Jackson) (Jung et al., 2000), B6.SJL-
ptprca mice congenic at the CD45 locus (B6.SJL mice), and B6.Rag1gfp/+
(Kuwata et al., 1999) mice weremaintained in our SPF facility. All animal exper-
iments were approved by the Institutional Animal Care Committee of Tokyo
Medical and Dental University.
Cell Sorting and Flow Cytometric Analysis
BM lineage negative (Lin) cells were immunomagnetically pre-enriched with
PE-Cy5-conjugated antibodies against lineage antigens including CD3ε
(145-2C11), CD4 (GK1.5), CD8a (53-6.7), B220 (RA3-6B2), CD19 (MB19-1),
CD11c (N418), MHC class II (I-A and I-E; M5/114.15.2), CD11b (M1/70),
Gr-1 (RB6-8C5), TER119 (TER119), NK1.1 (PK136) (all from BioLegend), and
anti-Cy5-MicroBeads (Miltenyi Biotec). BM Lin cells were then stained with
FITC-anti-CD34 (RAM34), PE-anti-Flt3 (A2F10.1), PE-Cy7-anti-Sca-1 (D7),
APC-anti-c-Kit (ACK2), Brilliant Violet 421-anti-IL-7Ra (A7P34), and Biotin-
anti-M-CSFR (AFS-98) (all from BioLegend). Secondary labeling was per-
formed with Streptavidin-APC-eFluor 780 (eBioscience). M-CSFR DC pro-
genitors as well as MDPs, CDPs, and LMPPs were sorted as Linc-Kitint/lo
Flt3+M-CSFRIL-7Ra cells, Linc-Kit+Flt3+M-CSFR+ cells, Linc-Kitint/lo
Flt3+M-CSFR+ cells, and Linc-Kit+Sca-1+CD34+Flt3+ cells, respectively, on
a MoFlo instrument (Beckman Coulter) and analyzed on a FACSCanto II (BD
Biosciences) in conjunction with FlowJo software (TreeStar). Antibodies
against the following molecules were used for further phenotypic analysis of
DC progenitors: MHC class II (I-A and I-E; M5/114.15.2), CD11c (N418),
CD40 (1C10), and Siglec-H (eBio440c) (all from eBioscience), PDCA-1
(JF05-1C.2.4.1, Miltenyi Biotec), CD45RA (14.8, BD Biosciences), CCR9
(242503, R&D), Mpl (AMM2, Kyowa Hakko Kirin), and Ly49Q (NS34)
(Toyama-Sorimachi et al., 2004). The cells were analyzed on a FACSCalibur
or a FACSCanto II (BD Biosciences) in conjunction with FlowJo software
(TreeStar).
Limiting-Dilution Analysis
Limiting-dilution assays were performed as described (Onai et al., 2007). Ac6
stromal cells were seeded at a density of 5 3 103 cells per well in 96-well flat-
bottomed plates 1 day before starting coculture. Linc-Kitint/loFlt3+Figure 6. Relationship between the M-CSFR– DC Progenitors and CDP
SortedM-CSFRDC progenitors and CDPs (23 104) were cultured in the presenc
TPO (20 ng/ml), or hFlt3L-Ig + M-CSF (20 ng/ml) + hTPO (20 ng/ml).
(A) Flow cytometric profiles of the DC subsets.
(B) Absolute numbers of the pDC and cDC subpopulations (CD24hi cDCs and CD
(C) Expression of Mpl on DC progenitors cultured with human Flt3L-Ig for 2 days
(D) Relative E2-2 mRNA expression in cytokine-stimulated DC progenitors at the
(E) DC progenitors were labeled with CFSE and cultured as indicated for 2 days.
Data are representative of three independent experiments. Error bars in (B) and
954 Immunity 38, 943–957, May 23, 2013 ª2013 Elsevier Inc.M-CSFRIL-7Ra cells were sorted and plated on irradiated Ac6 cells at a
density of 100, 50, 10, 2, or 1 cells per well. Cells were cultured as described
(Onai et al., 2007) and analyzed on day 12. The frequency of pDCs and/or cDCs
derived from progenitors was evaluated on a FACSCanto II (BD) via ‘‘Loi de
Poisson’’ statistics. Only wells containing more than 128 cells were considered
positive. Statistics were calculated based on the mean values of each dilution
step; the correlation coefficient for curve extrapolation was r = 0.9706.
In Vivo Reconstitution Assays
Fifty thousand double-sorted M-CSFR DC progenitors from B6 mice
(CD45.1CD45.2+) were injected i.v. into lethally X-ray-irradiated (9 Gy, Faxi-
tron) B6.SJL mice (CD45.1+CD45.2). When irradiated, 2 3 105 recipient
type whole BM cells were added to the injections. Intra-BMT was performed
as described (Kushida et al., 2001). Fifty thousand double-sorted DC progen-
itors from B6 mice were suspended in 10 ml of PBS and carefully injected
through a hole in the bone into the BM cavity of nonirradiated B6.SJL mice
with a customized Ito microsyringe (Ito Corp.). Mice were killed 10 days after
the reconstitution, and their splenic progenies were analyzed for the frequency
of cDCs and pDCs. In some experiments, CFSE-labeled 23 105M-CSFRDC
progenitors, CDPs, MDPs, or 13 105 MPPs were directly injected into the BM
(intra-BMT) of nonirradiated B6.SJLmice. Three days after the transplantation,
the BMprogenies were resorted and cultured in the presence of irradiated Ac6,
Flt3L, and TPO for 8 days.
Quantitative RT-PCR
Total RNA was extracted with the RNeasy Mini Kit (QIAGEN), and cDNA was
synthesized with random hexamers and SuperScript III reverse transcriptase.
For real-time PCR, cDNA products equivalent to the RNAs from 500 cells were
amplified with a LightCycler480 SYBR Green I Master (Roche Diagnostics).
The data were normalized to the amount of gapdh RNA expression in each
sample. The primers used for real-time PCR were as follows: E2-2 sense,
50-TGAGATCAAATCCGACGA-30 and antisense, 50-CGTTATTGCTAGATCTT
GACCT-30; Irf8 sense, 50-AAGGGCGTGTTCGTGAAG-30 and antisense,
50-GGTGGCGTAGAATTGCTG-30; Sfpi1 sense, 50-ATGCACGTCCTCGATA
CTC-30 and antisense, 50-TCTCACCCTCCTCCTCATCT-30; Spib sense 50-CA
CTCCCAAACTGTTCAGC-30 and antisense, 50-TGGGGTACGGAGCATAAG-
30; Stat3 sense, 50-TGGGTGGAAAAGGACATCAG-30 and antisense, 50-GGA
ATGTGGGGGTAGAGGTA-37; Gfi1 sense 50-CAAGAAGGCGCACAGCTA-30
and antisense 50-GGGCTCCATTTTGGACTC-30; Batf3 sense, 50-AGACCCA
GAAGGCTGACAA-30 and antisense, 50-CTGCACAAAGTTCATAGGACAC-30;
Id2 sense, 50-CATGAACGACTGCTACTCCAA-30 and antisense, 50-GTGATG
CAGGCTGACGATAGT-30; and Gapdh sense, 50-TCCACCACCCTGTTGCTG
TA-30 and antisense, 50-ACCACAGTCCATGCCATCAC-30. Primers were syn-
thesized by Operon Biotechnologies.
DC Functional Assays
In some in vivo experiments, CpG (D-19, 5 mg) in 50 ml HBSS was mixed with
30 ml DOTAP reagent (Roche) and 20 ml HBSS for 15 min at room temperature
(CpG+DOTAP). CpG+DOTAP was injected into B6.SJL mice that were lethally
irradiated and transplanted with DC progenitors and the serum IFN-a was
evaluated by ELISA 24 hr after the injection.
Statistical Analysis
We evaluated the statistical significance of the obtained values by the two-
tailed Student’s t test. A p value of <0.05 was considered significant.s
e of hFlt3L-Ig (FL) (100 ng/ml), hFlt3L-Ig +M-CSF (20 ng/ml), hFlt3L-Ig + human
24lo cDCs) on day 8 of culture.
.
indicated time points during culture.
(D) show the mean ± SEM. *p < 0.01. See also Figure S5.
AB C
Figure 7. LMPPs Give Rise to M-CSFR– DC Progenitors, CDPs, and MDPs In Vivo
Sorted and CFSE-labeled LMPPs (1 3 105 cells) were transplanted directly into the BM (intra-BMT) of nonirradiated B6.SJL mice.
(A) Representative flow cytometric profiles of BM progenies 3 days after intra-BMT are shown.
(B) Representative flow cytometric profiles of the progenies of sorted CFSE+LMPP-derived c-Kitint/loFlt3+M-CSFR cells, c-Kitint/loFlt3+M-CSFR+ cells, and
c-Kit+Flt3+M-CSFR+ cells and were cultured in irradiated stromal cells Ac6 with Flt3-ligand and TPO for 8 days.
(C) Absolute numbers of pDC and cDCderived fromdifferent progenitors are shown. Error bars show themeans ± SEM (n = 4 from two independent experiments).
*p < 0.01.
See also Figure S6.
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